Read Article As seen in an Up and Down the Ladder STAT column, Ed Silverman interviewed Tracey Lodie, our newly appointed Chief Development Officer, to explore her interest beyond her...
Read More
BOSTON, March 18, 2024 - GRO Biosciences Inc. (“GRObio”), an emerging biotechnology company leveraging synthetic biology to expand the amino acid alphabet and deliver on the promise of protein therapeutics,...
Read More
LISTEN TO THE PODCAST In this episode, Biorasi CEO Chris O’Brien hosted scientist and entrepreneur Daniel J. Mandell, Ph.D. to discuss how his creativity and imagination led him on a...
Read More
Data represent promising new modalities for reversing autoimmune disease without immunosuppression and for eliminating anti-drug antibodies against immunogenic therapies BOSTON, September 27, 2023 - GRO Biosciences Inc. (“GRObio”), an emerging...
Read More
Read Article proto.life: Scientists have created an organism that defies the rules of biology by using nonstandard amino acids. And you probably have some questions. Katia Tarasava, PhD, interviewed our...
Read More
Read Article Julianna LeMieux, PhD, Senior Science Writer at Genetic Engineering & Biotechnology News, interviewed our CEO Dan Mandell, PhD, and describes how non-standard amino acids (NSAAs) enable a new...
Read More
LISTEN TO THE PODCAST CEO Dan Mandell joined Kevin Folta on the Talking Biotech Podcast for an in-depth, technical conversation on the potential of protein therapeutics. In this episode Dan...
Read More
WATCH THE VIDEO GRO Biosciences CEO Dan Mandell explains how combining computation and automation enables smaller companies to innovate at a pace and scale formerly relegated to large biotechnology companies....
Read More
LISTEN TO THE PODCAST In the same way that written English is built around an alphabet of just 26 letters, all life on Earth is built around a standard set...
Read More
BOSTON, April 11, 2023 - GRO Biosciences Inc. (“GRObio”), an emerging biotechnology company leveraging synthetic biology to expand the amino acid alphabet and deliver on the promise of protein therapeutics,...
Read More
